Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;143(3):319-30.
doi: 10.1111/imm.12349.

Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis

Affiliations
Review

Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis

Yun Zhou et al. Immunology. 2014 Nov.

Abstract

Immune homeostasis is a host characteristic that maintains biological balance within a host. Humans have evolved many host defence mechanisms that ensure the survival of individuals upon encountering a pathogenic infection, with recovery or persistence from a viral infection being determined by both viral factors and host immunity. Chronic viral infections, such as hepatitis B virus, hepatitis C virus and HIV, often result in chronic fluctuating viraemia in the face of host cellular and humoral immune responses, which are dysregulated by multi-faceted mechanisms that are incompletely understood. This review attempts to illuminate the mechanisms involved in this process, focusing on immune homeostasis in the setting of persistent viral infection from the aspects of host defence mechanism, including interferon-stimulated genes, apolipoprotein B mRNA editing enzyme catalytic polypeptide 3 (APOBEC3), autophagy and interactions of various immune cells, cytokines and regulatory molecules.

Keywords: HIV; hepatitis C virus; immune homeostasis; viral persistence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Viral persistence and immune homeostasis. With high viral load infection, virus may evade host immunity, leading to death (a) or illness (b) of the host. With anti-viral treatment, viral load may be reduced, leading to viral clearance or latency. Meanwhile, anti-viral treatment may cause mutation in the virus and drug-resistance (b). When immune homeostasis is maintained, the host exhibits asymptomatic persistent infection, whereby the immune system fight against the virus; and viral load fluctuates during chronic infection (c). Under a strong host immune response, viral infection may become latent (d) or be cleared (e).

Similar articles

Cited by

References

    1. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306. - PubMed
    1. Harrison OJ, Maloy KJ. Innate immune activation in intestinal homeostasis. J Innate Immun. 2011;3:585–93. - PMC - PubMed
    1. Helle F, Dubuisson J. Hepatitis C virus entry into host cells. Cell Mol Life Sci. 2008;65:100–12. - PMC - PubMed
    1. von Hahn T, Rice CM. Hepatitis C virus entry. J Biol Chem. 2008;283:3689–93. - PubMed
    1. Fofana I, Fafi-Kremer S, Carolla P, et al. Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. Gastroenterology. 2012;143:223–33. e9. - PMC - PubMed

Publication types

LinkOut - more resources